PARP1 and colorectal carcinoma: The third major novelty of this study is the evidence of a functional link between MRE11 and RAD51 with crucial implication for genoprotection, mitosis and survival of PARP1-overexpressing CRC-SCs, including those resistant to irinotecan and ATRi/CHK1i.